Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
129M
-
Number of holders
-
266
-
Total 13F shares, excl. options
-
123M
-
Shares change
-
-2.6M
-
Total reported value, excl. options
-
$1.82B
-
Value change
-
-$36.3M
-
Put/Call ratio
-
0.17
-
Number of buys
-
99
-
Number of sells
-
-119
-
Price
-
$14.75
Significant Holders of NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) as of Q3 2024
299 filings reported holding NEO - NEOGENOMICS INC - Common Stock, $0.01 par value as of Q3 2024.
NEOGENOMICS INC - Common Stock, $0.01 par value (NEO) has 266 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 123M shares
of 129M outstanding shares and own 95.52% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (19.9M shares), VANGUARD GROUP INC (14M shares), BROWN ADVISORY INC (6.89M shares), JANUS HENDERSON GROUP PLC (6.6M shares), T. Rowe Price Investment Management, Inc. (6.54M shares), STATE STREET CORP (4.96M shares), Greenhouse Funds LLLP (4.46M shares), SCHRODER INVESTMENT MANAGEMENT GROUP (4.22M shares), MACQUARIE GROUP LTD (3.82M shares), and DIMENSIONAL FUND ADVISORS LP (3.36M shares).
This table shows the top 266 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.